Exact Mass: 401.0754

Exact Mass Matches: 401.0754

Found 34 metabolites which its exact mass value is equals to given mass value 401.0754, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Fenoldopam mesylate

Fenoldopam (mesylate)

C17H20ClNO6S (401.07)


D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018491 - Dopamine Agonists D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents C78272 - Agent Affecting Nervous System > C66884 - Dopamine Agonist D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents Fenoldopam mesylate (SKF-82526) is a D1 receptor agonist and a novel lysine-specific demethylase 1 (LSD1) inhibitor (IC50=0.8974 μM). Fenoldopam mesylate shows anti-hypertensive effects, anti-cancer cell proliferation activity and can induce cells apoptosis[1][2][3].

   

5-Hexenyl glucosinolate

{[(e)-(1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulphanyl}hept-6-en-1-ylidene)amino]oxy}sulphonic acid

C13H23NO9S2 (401.0814)


Present in horseradish (Armoracia lapathifolia) and Japanese horseradish (Wasabia japonica). 5-Hexenyl glucosinolate is found in many foods, some of which are horseradish, wasabi, brassicas, and radish. 5-Hexenyl glucosinolate is found in brassicas. 5-Hexenyl glucosinolate is present in horseradish (Armoracia lapathifolia) and Japanese horseradish (Wasabia japonica).

   
   
   
   

8-Acetamido-1,1,15,15-tetrachloropentadeca-3-yne

8-Acetamido-1,1,15,15-tetrachloropentadeca-3-yne

C17H27Cl4NO (401.0847)


   

5-Hydroxylansoprazole sulfone

5-Hydroxylansoprazole sulfone

C16H14F3N3O4S (401.0657)


   

5-Hexenyl glucosinolate

{[(E)-(1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl}hept-6-en-1-ylidene)amino]oxy}sulfonic acid

C13H23NO9S2 (401.0814)


   

penflutizide

penflutizide

C13H18F3N3O4S2 (401.0691)


C78275 - Agent Affecting Blood or Body Fluid > C448 - Diuretic > C49185 - Thiazide Diuretic

   

Benzenepropanoic acid, α-[[(6-amino-3,5-difluoro-2-pyridinyl)amino]methylene]-2,4,5-trifluoro-β-oxo-, ethyl ester

Benzenepropanoic acid, α-[[(6-amino-3,5-difluoro-2-pyridinyl)amino]methylene]-2,4,5-trifluoro-β-oxo-, ethyl ester

C17H12F5N3O3 (401.0799)


   

chloro-tris(2,3,4,5,6-pentadeuteriophenyl)stannane

chloro-tris(2,3,4,5,6-pentadeuteriophenyl)stannane

C18ClD15Sn (401.0826)


   

Adenosine 3′,5′-cyclic monophosphate acetoxymethyl ester

Adenosine 3′,5′-cyclic monophosphate acetoxymethyl ester

C13H16N5O8P (401.0736)


   

clinafloxacin hydrochloride

clinafloxacin hydrochloride

C17H18Cl2FN3O3 (401.0709)


C254 - Anti-Infective Agent > C258 - Antibiotic > C795 - Quinolone Antibiotic

   

2-nitrooxyethyl 2-(5-hydroxy-4-oxo-2-phenylchromen-7-yl)oxyacetate

2-nitrooxyethyl 2-(5-hydroxy-4-oxo-2-phenylchromen-7-yl)oxyacetate

C19H15NO9 (401.0747)


   

Lansoprazole Sulfone N-Oxide

Lansoprazole Sulfone N-Oxide

C16H14F3N3O4S (401.0657)


   

[(2S)-3-[[(1S)-1-(3,4-dichlorophenyl)ethyl]amino]-2-hydroxypropyl]-(phenylmethyl)phosphinic acid

[(2S)-3-[[(1S)-1-(3,4-dichlorophenyl)ethyl]amino]-2-hydroxypropyl]-(phenylmethyl)phosphinic acid

C18H22Cl2NO3P (401.0714)


D018377 - Neurotransmitter Agents > D018682 - GABA Agents > D018756 - GABA Antagonists

   

2-{1-[2-(2-Amino-thiazol-4-YL)-2-methoxyimino-acetylamino]-2-oxo-ethyl}-5,5-dimethyl-thiazolidine-4-carboxylic acid

2-{1-[2-(2-Amino-thiazol-4-YL)-2-methoxyimino-acetylamino]-2-oxo-ethyl}-5,5-dimethyl-thiazolidine-4-carboxylic acid

C14H19N5O5S2 (401.0828)


   

Cephalexin hydrochloride

Cephalexin hydrochloride

C16H20ClN3O5S (401.0812)


D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D002511 - Cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic

   

grixazone A

grixazone A

C18H15N3O6S (401.0682)


A cysteine derivative that is the S-(2-amino-8-formyl-3-oxo-3H-phenoxazin-1-yl) derivative of N-acetyl-L-cysteine.

   

8-O-desmethylanthrotainin

8-O-desmethylanthrotainin

C19H15NO9 (401.0747)


   

4-oxo-5-phenyl-1,2-dihydro-4H-pyrrolo[3,2,1-ij]quinolin-6-yl 4-chlorobenzoate

4-oxo-5-phenyl-1,2-dihydro-4H-pyrrolo[3,2,1-ij]quinolin-6-yl 4-chlorobenzoate

C24H16ClNO3 (401.0819)


   

4-Pyridinecarboxylic acid 4-[[5-(1-naphthalenyl)-1,3,4-oxadiazol-2-yl]thio]but-2-ynyl ester

4-Pyridinecarboxylic acid 4-[[5-(1-naphthalenyl)-1,3,4-oxadiazol-2-yl]thio]but-2-ynyl ester

C22H15N3O3S (401.0834)


   

1-[(3aR,4R,9bR)-8-bromo-4-(hydroxymethyl)-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-1-yl]-2-pyridin-4-ylethanone

1-[(3aR,4R,9bR)-8-bromo-4-(hydroxymethyl)-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-1-yl]-2-pyridin-4-ylethanone

C19H20BrN3O2 (401.0739)


   

1-[(3aS,4S,9bS)-8-bromo-4-(hydroxymethyl)-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-1-yl]-2-pyridin-4-ylethanone

1-[(3aS,4S,9bS)-8-bromo-4-(hydroxymethyl)-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-1-yl]-2-pyridin-4-ylethanone

C19H20BrN3O2 (401.0739)


   

4-Demethylwyosine 5-monophosphate

4-Demethylwyosine 5-monophosphate

C13H16N5O8P (401.0736)


   

[5-[2-amino-5-(formamidomethyl)-4-oxo-3H-pyrrolo[2,3-d]pyrimidin-7-yl]-3-hydroxy-2,5-dihydrofuran-2-yl]methyl dihydrogen phosphate

[5-[2-amino-5-(formamidomethyl)-4-oxo-3H-pyrrolo[2,3-d]pyrimidin-7-yl]-3-hydroxy-2,5-dihydrofuran-2-yl]methyl dihydrogen phosphate

C13H16N5O8P (401.0736)


   

[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] prop-2-enoate

[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] prop-2-enoate

C13H16N5O8P (401.0736)


   

SIRT5 inhibitor 3

SIRT5 inhibitor 3

C22H12FN3O4 (401.0812)


SIRT5 inhibitor 3 (compound 46) is a potent and competitive SIRT5 inhibitor with an IC50 value of 5.9 μM. SIRT5 inhibitor 3 can inhibit SIRT5 desuccinylation. SIRT5 inhibitor 3 can be used for researching cancer and neurodegenerative diseases[1].

   

n-(1,3,3,4-tetrachloropentadec-1-yn-4-yl)ethanimidic acid

n-(1,3,3,4-tetrachloropentadec-1-yn-4-yl)ethanimidic acid

C17H27Cl4NO (401.0847)


   

3-[(2-amino-8-formyl-3-oxophenoxazin-1-yl)sulfanyl]-2-[(1-hydroxyethylidene)amino]propanoic acid

3-[(2-amino-8-formyl-3-oxophenoxazin-1-yl)sulfanyl]-2-[(1-hydroxyethylidene)amino]propanoic acid

C18H15N3O6S (401.0682)


   

(4ar,12ar)-1,4a,8,10,11,12a-hexahydroxy-3,12-dioxo-4,5-dihydrotetracene-2-carboximidic acid

(4ar,12ar)-1,4a,8,10,11,12a-hexahydroxy-3,12-dioxo-4,5-dihydrotetracene-2-carboximidic acid

C19H15NO9 (401.0747)


   

n-[(8r)-1,1,15,15-tetrachloropentadec-3-yn-8-yl]ethanimidic acid

n-[(8r)-1,1,15,15-tetrachloropentadec-3-yn-8-yl]ethanimidic acid

C17H27Cl4NO (401.0847)


   

(2r)-3-[(2-amino-8-formyl-3-oxophenoxazin-1-yl)sulfanyl]-2-[(1-hydroxyethylidene)amino]propanoic acid

(2r)-3-[(2-amino-8-formyl-3-oxophenoxazin-1-yl)sulfanyl]-2-[(1-hydroxyethylidene)amino]propanoic acid

C18H15N3O6S (401.0682)


   

n-(1,1,15,15-tetrachloropentadec-3-yn-8-yl)ethanimidic acid

n-(1,1,15,15-tetrachloropentadec-3-yn-8-yl)ethanimidic acid

C17H27Cl4NO (401.0847)